Dr. Gilotra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 North Caroline Street
Baltimore, MD 21287Phone+1 443-997-0270Fax+1 410-614-1168
Education & Training
- Johns Hopkins UniversityFellowship, Advanced Heart Failure and Transplant Cardiology, 2016
- Johns Hopkins UniversityFellowship, Cardiovascular Disease, 2015
- Johns Hopkins UniversityResidency, Internal Medicine, 2008 - 2011
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2008
Certifications & Licensure
- MD State Medical License 2011 - 2026
Clinical Trials
- Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of ITI-214 in Patients With Heart Failure Start of enrollment: 2018 Jul 10
- Heart Failure Event Advance Detection Trial Start of enrollment: 2020 Feb 04
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Impaired Atrial and Ventricular Strain Predicts Heart Failure in Arrhythmogenic Right Ventricular Cardiomyopathy.Xander Jacquemyn, Jef Van den Eynde, Junzhen Zhan, Ashish N Doshi, William J Ravekes
The Canadian Journal of Cardiology. 2024-11-29 - 1 citationsPulmonary sarcoidosis: differences in lung function change over time.Michelle Sharp, Kevin J Psoter, Ali M Mustafa, Edward S Chen, Nancy W Lin
Thorax. 2024-10-16 - Clinical features and outcomes in carriers of pathogenic desmoplakin variants.Alessio Gasperetti, Richard T Carrick, Alexandros Protonotarios, Brittney Murray, Mikael Laredo
European Heart Journal. 2024-09-17
Journal Articles
- Combination Therapy with Prednisone and Mycophenolate Mofetil in the Management of Cardiac SarcoidosisEdward K Kasper, Nisha A Gilotra, Journal of Cardiac Failure
- Endothelial PD-L1 Expression as a Biomarker for Acute Rejection in Heart TransplantationNisha A Gilotra, Ilan S Wittstein, Journal of Cardiac Failure
Authored Content
- Combination Therapy with Prednisone and Mycophenolate Mofetil in the Management of Cardiac SarcoidosisSeptember 2018
- Endothelial PD-L1 Expression as a Biomarker for Acute Rejection in Heart TransplantationAugust 2018
- A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplantation Mechanical Circulatory Support Outcomes in Cardiac SarcoidosisFebruary 2018
- A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplantation Mechanical Circulatory Support Outcomes in Cardiac SarcoidosisFebruary 2018
- Join now to see all
Press Mentions
- Myocarditis and COVID Vaccines: What You Need to Know NowOctober 6th, 2021
- 'A Sicker Nation': COVID Causing Increases in Heart Disease in U.S., Studies ShowAugust 20th, 2023
- Cardiac SarcoidosisJanuary 18th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: